SCHEMBL8853802

SCHEMBL8853802

C#C[C@]1(OC(=O)CCC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.79
▸ PGR P06401 6/20 0.79
▸ ABCB11 O95342 5/20 0.79
▸ CYP2C19 P33261 4/20 0.79
▸ NR3C1 P04150 4/20 0.79
▸ AR P10275 4/20 0.79
▸ MAPT P10636 3/20 0.79
▸ MEN1 O00255 3/20 0.79
▸ KMT2A Q03164 3/20 0.79
▸ ADORA3 P0DMS8 3/20 0.79
▸ SLC6A2 P23975 3/20 0.79
▸ CHRM1 P11229 2/20 0.79
▸ ADRA1A P35348 2/20 0.79
▸ MAPK1 P28482 2/20 0.79
▸ CHRM2 P08172 1/20 0.79
▸ TBXA2R P21731 1/20 0.79
▸ LMNA P02545 6/20 0.63
▸ SLC6A4 P31645 4/20 0.63
▸ ESR1 P03372 3/20 0.63
▸ SHBG P04278 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL354296 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL11694460 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL31432443 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL8853780 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL372672 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL11696763 0.93 CYP3A4 (0.74) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL8853605 0.93 CYP3A4 (0.82) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL18171759 0.92 CYP3A4 (0.78) CYP3A4PGRABCB11CYP2C19NR3C1
SCHEMBL10624499 0.91 CYP3A4 (0.82) CYP3A4PGRABCB11CYP2C19NR3C1
Norethindrone Acetate SCHEMBL8816427 0.90 CYP3A4 (0.81) CYP3A4PGRABCB11CYP2C19NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5595759-A Process for providing therapeutic composition ALZA CORPORATION (US) 1997-01-21 — — US disclosed
Send feedback